A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund. | A ...

Apellis Pharmaceuticals focuses on creating medicines targeting eye diseases and rare neurological diseases. Read why I rate ...

The company is reimagining the fragmented reality of molecular research by building the world's largest RNA sequencing ...

Moderna's stock crash may be overdone. Discover why its pipeline, mRNA/AI prospects, and strong balance sheet signal ...

Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” first quarter ...